Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001

Deborah M. Stephens; Hongli Li; Louis S. Constine; Thomas J. Fitzgerald; John P. Leonard; Brad S. Kahl; Joo Y. Song; Michael L. LeBlanc; Sonali M. Smith; Daniel O. Persky; Jonathan W. Friedberg

doi:10.3324/haematol.2022.281004

Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001

Deborah M. Stephens, Hongli Li, Louis S. Constine, Thomas J. Fitzgerald, John P. Leonard, Brad S. Kahl, Joo Y. Song, Michael L. LeBlanc, Sonali M. Smith, Daniel O. Persky, Jonathan W. Friedberg

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	2732-2736
Number of pages	5
Journal	Haematologica
Volume	107
Issue number	11
DOIs	https://doi.org/10.3324/haematol.2022.281004
State	Published - Nov 2022

Access to Document

10.3324/haematol.2022.281004

Cite this

Stephens, D. M., Li, H., Constine, L. S., Fitzgerald, T. J., Leonard, J. P., Kahl, B. S., Song, J. Y., LeBlanc, M. L., Smith, S. M., Persky, D. O., & Friedberg, J. W. (2022). Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001. Haematologica, 107(11), 2732-2736. https://doi.org/10.3324/haematol.2022.281004

@article{35f482be1881483ba94d926e0463d7bd,

title = "Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001",

author = "Stephens, {Deborah M.} and Hongli Li and Constine, {Louis S.} and Fitzgerald, {Thomas J.} and Leonard, {John P.} and Kahl, {Brad S.} and Song, {Joo Y.} and LeBlanc, {Michael L.} and Smith, {Sonali M.} and Persky, {Daniel O.} and Friedberg, {Jonathan W.}",

note = "Funding Information: NIH/NCI/NCTN grants U10CA180888, U10CA180819, U10CA180820, U10CA180821, U10CA180882; and by Spectrum Pharmaceuticals, Inc. and Biogen IDEC Pharmaceuticals Corp. (Biogen Inc.).",

year = "2022",

month = nov,

doi = "10.3324/haematol.2022.281004",

language = "English",

volume = "107",

pages = "2732--2736",

journal = "Haematologica",

issn = "0390-6078",

number = "11",

}

Stephens, DM, Li, H, Constine, LS, Fitzgerald, TJ, Leonard, JP, Kahl, BS, Song, JY, LeBlanc, ML, Smith, SM, Persky, DO & Friedberg, JW 2022, 'Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001', Haematologica, vol. 107, no. 11, pp. 2732-2736. https://doi.org/10.3324/haematol.2022.281004

TY - JOUR

T1 - Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001

AU - Stephens, Deborah M.

AU - Li, Hongli

AU - Constine, Louis S.

AU - Fitzgerald, Thomas J.

AU - Leonard, John P.

AU - Kahl, Brad S.

AU - Song, Joo Y.

AU - LeBlanc, Michael L.

AU - Smith, Sonali M.

AU - Persky, Daniel O.

AU - Friedberg, Jonathan W.

N1 - Funding Information: NIH/NCI/NCTN grants U10CA180888, U10CA180819, U10CA180820, U10CA180821, U10CA180882; and by Spectrum Pharmaceuticals, Inc. and Biogen IDEC Pharmaceuticals Corp. (Biogen Inc.).

PY - 2022/11

Y1 - 2022/11

UR - http://www.scopus.com/inward/record.url?scp=85141301530&partnerID=8YFLogxK

U2 - 10.3324/haematol.2022.281004

DO - 10.3324/haematol.2022.281004

M3 - Letter

C2 - 35833300

AN - SCOPUS:85141301530

SN - 0390-6078

VL - 107

SP - 2732

EP - 2736

JO - Haematologica

JF - Haematologica

IS - 11

ER -

Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001

Access to Document

Other files and links

Cite this